News
Videos
Conferences
Events
Resources
Subscribe

Treating With Venetoclax for Chronic Lymphocytic Leukemia: Samantha’s Story

EP. 1: The First Signs of Leukemia

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 2: Chronic Lymphocytic Leukemia Diagnostic Process

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 3: CLL Treatment Decision Factors

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 4: First-Hand Experience with CD20 Monoclonal Antibody Therapy

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 5: CD20 Monoclonal Antibody Dose Adjustment and MRD

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 6: The Patient's Role in Deciding a Treatment

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 7: Achieving Minimum Residual Disease Remission

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 8: Chronic Lymphocytic Leukemia Support Network

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 9: Advice for Patient's and Caregivers

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

EP. 10: Lifestyle Changes After Being Diagnosed with CLL

ByNitin Jain, MD, MD Anderson Cancer Center,Samantha Rine,Doug Rine

October 14th 2020

Trending on CURE

A New Option Without Traditional Chemotherapy for Ph+ ALL

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

Azacitidine Plus Venclexta Superior to Chemo in Acute AML

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit

© 2025 MJH Life Sciences^®

All rights reserved.